NCT07593508

Brief Summary

This randomized controlled clinical trial evaluates whether adjunctive 808-nm diode laser therapy after direct pulp capping reduces postoperative pain and dentin hypersensitivity compared with conventional Biodentine treatment. Sixty teeth from fifty-six participants with carious pulp exposure were randomly allocated into two treatment groups. Postoperative pain, dentin hypersensitivity, and 6-month clinical success rates were assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

May 11, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 18, 2026

Completed
Last Updated

May 18, 2026

Status Verified

May 1, 2026

Enrollment Period

2.2 years

First QC Date

May 11, 2026

Last Update Submit

May 11, 2026

Conditions

Keywords

Direct pulp cappingBiodentineDiode laserPostoperative painDentin hypersensitivityVital pulp therapy

Outcome Measures

Primary Outcomes (2)

  • Dentin Hypersensitivity

    Dentin hypersensitivity will be assessed using a cold stimulus test (0-4°C water) and recorded using the Numerical Rating Scale (NRS, 0-10), where higher scores indicate greater sensitivity.

    1 month, 3 months, and 6 months after treatment

  • Postoperative Pain Intensity

    Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 indicates the worst pain imaginable. Participants will record daily pain scores until complete pain resolution.

    Daily until complete pain resolution (up to 7 days after treatment)

Secondary Outcomes (1)

  • Clinical Success Rate

    6 months after treatment

Study Arms (2)

Conventional Biodentine Direct Pulp Capping

ACTIVE COMPARATOR

Eligible teeth received conventional direct pulp capping treatment. After local anesthesia and rubber dam isolation, caries removal and cavity preparation were performed. Hemostasis was achieved using saline-moistened cotton pellets followed by 3% sodium hypochlorite disinfection. Biodentine was placed over the pulp exposure site and the tooth was restored using a selective-etch composite restoration protocol.

Device: Biodentine

Diode Laser-Assisted Biodentine Direct Pulp Capping

EXPERIMENTAL

Eligible teeth received adjunctive 808-nm diode laser therapy during direct pulp capping. After standard cavity preparation, diode laser irradiation was applied for hemostasis and disinfection before placement of Biodentine and definitive composite restoration. The laser protocol included standardized irradiation parameters for pulp hemostasis and cavity disinfection.

Device: BiodentineDevice: 808-nm Diode Laser

Interventions

Biodentine was used as a bioactive tricalcium silicate pulp-capping material placed directly over the exposed pulp tissue following hemostasis and cavity disinfection.

Conventional Biodentine Direct Pulp CappingDiode Laser-Assisted Biodentine Direct Pulp Capping

Adjunctive diode laser irradiation was applied for hemostasis and disinfection before Biodentine placement during direct pulp capping.

Diode Laser-Assisted Biodentine Direct Pulp Capping

Eligibility Criteria

Age10 Years - 58 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Participants aged 10 to 58 years.
  • Teeth with pulp exposure caused by caries removal.
  • Vital teeth confirmed by clinical pulp vitality tests (cold and heat tests) and radiographic examination.
  • No history of spontaneous pain; only mild or tolerable discomfort to cold stimuli.
  • Pulp exposure less than 2 mm in diameter.
  • Normal radiographic findings with no periapical pathology.
  • Bleeding controllable within 10 minutes.
  • Written informed consent obtained from participants or legal guardians.

You may not qualify if:

  • Pulp exposure caused by trauma or occlusal wear.
  • Teeth unsuitable for restoration, including subgingival fractures or vertical root cracks.
  • Clinical signs of irreversible pulpitis, abscess, or sinus tract.
  • Uncontrollable bleeding after 10 minutes of saline pressure or laser hemostasis.
  • Previous use of analgesics before treatment.
  • Multiple pulp exposures in the same dental arch.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Odonto-Stomatology, Hue University of Medicine and Pharmacy

Huế, 49000, Vietnam

Location

Related Publications (2)

  • Yazdanfar I, Barekatain M, Zare Jahromi M. Combination effects of diode laser and resin-modified tricalcium silicate on direct pulp capping treatment of caries exposures in permanent teeth: a randomized clinical trial. Lasers Med Sci. 2020 Oct;35(8):1849-1855. doi: 10.1007/s10103-020-03052-9. Epub 2020 Jun 11.

    PMID: 32529588BACKGROUND
  • Yazdanfar I, Gutknecht N, Franzen R. Effects of diode laser on direct pulp capping treatment : a pilot study. Lasers Med Sci. 2015 May;30(4):1237-43. doi: 10.1007/s10103-014-1574-8. Epub 2014 Apr 23.

    PMID: 24756324BACKGROUND

MeSH Terms

Conditions

Dental Pulp ExposurePain, PostoperativeDentin Sensitivity

Interventions

Lasers, Semiconductor

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Anh Chi PHAN, PhD

    Hue University of Medicine and Pharmacy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the nature of the intervention, blinding of participants and care providers was not feasible because diode laser application was visible and audible during treatment. However, the outcome assessor responsible for evaluating postoperative pain, dentin hypersensitivity, and clinical follow-up outcomes was blinded to group allocation throughout the study. All assessment forms were coded by participant ID without treatment information, and participants were instructed not to disclose their treatment assignment during follow-up visits.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized, parallel-group clinical trial in which eligible teeth with carious pulp exposure were allocated in a 1:1 ratio to either conventional direct pulp capping with Biodentine (control group) or diode laser-assisted direct pulp capping with Biodentine (experimental group). Randomization was performed at the tooth level using a computer-generated sequence with allocation concealment by sequentially numbered, opaque, sealed envelopes (SNOSE). Clinical outcomes were evaluated at predefined follow-up intervals by a blinded outcome assessor.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2026

First Posted

May 18, 2026

Study Start

July 1, 2022

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

May 18, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) underlying the results reported in this study will be shared, including demographic characteristics, postoperative pain scores, dentin hypersensitivity scores, and clinical follow-up outcomes. All personal identifiers will be removed to protect participant confidentiality.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available beginning 6 months following publication and will remain available for 5 years thereafter.
Access Criteria
Access will be provided to qualified researchers who submit a methodologically sound proposal for secondary analyses or meta-analysis. Requests should be directed to the corresponding author by email and will be reviewed by the study investigators.

Locations